精华制药(002349.SZ)：前三季度净利润1.76亿元 同比增加7.39%

Core Viewpoint - Jinghua Pharmaceutical (002349.SZ) reported a revenue of 1.092 billion yuan for the first three quarters of 2025, reflecting a year-on-year increase of 4.51% [1] - The net profit attributable to shareholders reached 176 million yuan, marking a year-on-year increase of 7.39% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 170 million yuan, showing a year-on-year increase of 9.17% [1] - Basic earnings per share stood at 0.2148 yuan [1] Financial Performance - Revenue for the first three quarters: 1.092 billion yuan, up 4.51% year-on-year [1] - Net profit attributable to shareholders: 176 million yuan, up 7.39% year-on-year [1] - Net profit after deducting non-recurring items: 170 million yuan, up 9.17% year-on-year [1] - Basic earnings per share: 0.2148 yuan [1]